HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation.

Abstract
Purpose To construct a nomogram with the albumin-bilirubin (ALBI) grade to assess the long-term outcomes of patients with early-stage hepatocellular carcinoma (HCC) after radiofrequency ablation (RFA). Materials and Methods This retrospective study was approved by the institutional review board, and informed consent was waived. We studied 622 treatment-naïve patients with HCC according to the Milan criteria who subsequently underwent RFA from 2002 to 2013. Baseline characteristics were collected to identify the risk factors for determination of poor overall survival after RFA. The multivariate Cox proportional hazards model based on significant prognostic factors of overall survival was used to construct the nomogram. Results After a median follow-up time of 35.7 months, 190 patients had died. The cumulative 5- and 10-year overall survival rates were 63.1% and 48.7%, respectively. Stratified according to ALBI grade, the cumulative 5- and 10-year survival rates were 80.0% and 67.9% for patients with grade 1, respectively, and 48.6% and 35.1% for those with grades 2-3, respectively (P < .001). Multivariate analysis results showed that patient age older than 65 years, a prothrombin time international normalized ratio greater than 1.1, α-fetoprotein level greater than 20 ng/mL, multiple tumors, and ALBI grade 2 or 3 were associated with overall mortality. A nomogram was developed on the basis of these five variables. Internal validation with 200 bootstrapped sample sets had a good concordance index of 0.770 (95% confidence interval: 0.633, 0.876). Conclusion This simple nomogram based on the ALBI grade offers personalized long-term survival data for patients with early-stage HCC who undergo RFA. © RSNA, 2017 Online supplemental material is available for this article.
AuthorsWei-Yu Kao, Chien-Wei Su, Yi-You Chiou, Nai-Chi Chiu, Chien-An Liu, Kuan-Chieh Fang, Teh-Ia Huo, Yi-Hsiang Huang, Chun-Chao Chang, Ming-Chih Hou, Han-Chieh Lin, Jaw-Ching Wu
JournalRadiology (Radiology) Vol. 285 Issue 2 Pg. 670-680 (11 2017) ISSN: 1527-1315 [Electronic] United States
PMID28562211 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Albumins
  • Bilirubin
Topics
  • Aged
  • Albumins (analysis)
  • Bilirubin (blood)
  • Carcinoma, Hepatocellular (blood, epidemiology, mortality, surgery)
  • Catheter Ablation (mortality, statistics & numerical data)
  • Female
  • Humans
  • Liver Neoplasms (blood, epidemiology, mortality, surgery)
  • Male
  • Middle Aged
  • Nomograms
  • Retrospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: